Pulmonary dendritic cell subsets shape the respiratory syncytial virus-specific CD8+ T cell immunodominance hierarchy in neonates

Journal of Immunology

Volumn 198, Issue 1, 2017, Pages 394-403

  Malloy, Allison M W ^a,b   Ruckwardt, Tracy J ^b   Morabito, Kaitlyn M ^b   Lau Kilby, Annie W ^a   Graham, Barney S ^b  

^a Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD103 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; EPITOPE; TOLL LIKE RECEPTOR AGONIST;

ADULT; AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; IMMUNODOMINANCE HIERARCHY; INNATE IMMUNITY; MALE; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SIGNAL TRANSDUCTION; ANIMAL; CELL SEPARATION; DISEASE MODEL; FLOW CYTOMETRY; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; LUNG; VIROLOGY;

ANIMALS; ANIMALS, NEWBORN; CD8-POSITIVE T-LYMPHOCYTES; CELL SEPARATION; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNODOMINANT EPITOPES; LUNG; MICE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES;

EID: 85006963151     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1600486     Document Type: Article

References (63)

1. Lozano, R., M. Naghavi, K. Foreman, S. Lim, K. Shibuya, V. Aboyans, J. Abraham, T. Adair, R. Aggarwal, S. Y. Ahn, et al. 2012. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2095-2128.
2. + T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections. J. Immunol. 179: 8410-8417.
3. + T-cell activation during natural respiratory syncytial virus infection in infants. J. Virol. 84: 2374-2383.
4. Harris, D. T., M. J. Schumacher, J. Locascio, F. J. Besencon, G. B. Olson, D. DeLuca, L. Shenker, J. Bard, and E. A. Boyse. 1992. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl. Acad. Sci. USA 89: 10006-10010.
5. Adkins, B., C. Leclerc, and S. Marshall-Clarke. 2004. Neonatal adaptive immunity comes of age. Nat. Rev. Immunol. 4: 553-564.
6. Prendergast, A. J., P. Klenerman, and P. J. Goulder. 2012. The impact of differential antiviral immunity in children and adults. Nat. Rev. Immunol. 12: 636-648.
7. + T lymphocyte response to viral infection during fetal life. J. Clin. Invest. 111: 1747-1755.
8. Hermann, E., C. Truyens, C. Alonso-Vega, J. Even, P. Rodriguez, A. Berthe, E. Gonzalez-Merino, F. Torrico, and Y. Carlier. 2002. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 100: 2153-2158.
9. Franchini, M., C. Abril, C. Schwerdel, C. Ruedl, M. Ackermann, and M. Suter. 2001. Protective T-cell-based immunity induced in neonatal mice by a single replicative cycle of herpes simplex virus. J. Virol. 75: 83-89.
10. Martinez, X., C. Brandt, F. Saddallah, C. Tougne, C. Barrios, F. Wild, G. Dougan, P. H. Lambert, and C. A. Siegrist. 1997. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc. Natl. Acad. Sci. USA 94: 8726-8731.
11. Brazolot Millan, C. L., R. Weeratna, A. M. Krieg, C. A. Siegrist, and H. L. Davis. 1998. CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice. Proc. Natl. Acad. Sci. USA 95: 15553-15558.
12. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
13. Sigal, L. J., and K. L. Rock. 2000. Bone marrow-derived antigen-presenting cells are required for the generation of cytotoxic T lymphocyte responses to viruses and use transporter associated with antigen presentation (TAP)-dependent and -independent pathways of antigen presentation. J. Exp. Med. 192: 1143-1150.
14. Lenz, L. L., E. A. Butz, and M. J. Bevan. 2000. Requirements for bone marrow-derived antigen-presenting cells in priming cytotoxic T cell responses to intracellular pathogens. J. Exp. Med. 192: 1135-1142.
15. Gilchuk, P., C. T. Spencer, S. B. Conant, T. Hill, J. J. Gray, X. Niu, M. Zheng, J. J. Erickson, K. L. Boyd, K. J. McAfee, et al. 2013. Discovering naturally processed antigenic determinants that confer protective T cell immunity. J. Clin. Invest. 123: 1976-1987.
16. + T cell immunodominance. J. Immunol. 181: 2124-2133.
17. Cukalac, T., J. Chadderton, W. Zeng, J. G. Cullen, W. T. Kan, P. C. Doherty, D. C. Jackson, S. J. Turner, and N. L. La Gruta. 2014. The influenza virus-specific CTL immunodominance hierarchy in mice is determined by the relative frequency of high-avidity T cells. J. Immunol. 192: 4061-4068.
18. Wherry, E. J., K. A. Puorro, A. Porgador, and L. C. Eisenlohr. 1999. The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attained. J. Immunol. 163: 3735-3745.
19. Probst, H. C., K. Tschannen, A. Gallimore, M. Martinic, M. Basler, T. Dumrese, E. Jones, and M. F. van den Broek. 2003. Immunodominance of an antiviral cytotoxic T cell response is shaped by the kinetics of viral protein expression. J. Immunol. 171: 5415-5422.
20. CD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24: 817-819.
21. + T cell responses in an F1 hybrid mouse model of respiratory syncytial virus infection. Virology 362: 314-319.
22. Ruckwardt, T. J., A. M. Malloy, E. Gostick, D. A. Price, P. Dash, J. L. McClaren, P. G. Thomas, and B. S. Graham. 2011. Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice. PLoS Pathog. 7: e1002377.
23. + T cell response. PLoS Pathog. 10: e1003934.
24. Condon, T. V., R. T. Sawyer, M. J. Fenton, and D. W. Riches. 2011. Lung dendritic cells at the innate-adaptive immune interface. J. Leukoc. Biol. 90: 883-895.
25. + pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen. J. Exp. Med. 208: 1789-1797.
26. + T cell differentiation by a CD24-dependent mechanism. Immunity 40: 400-413.
27. Desch, A. N., S. L. Gibbings, E. T. Clambey, W. J. Janssen, J. E. Slansky, R. M. Kedl, P. M. Henson, and C. Jakubzick. 2014. Dendritic cell subsets require cis-activation for cytotoxic CD8 T-cell induction. Nat. Commun. 5: 4674.
28. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26: 153-162.
29. Sarzotti, M., D. S. Robbins, and P. M. Hoffman. 1996. Induction of protective CTL responses in newborn mice by a murine retrovirus. Science 271: 1726-1728.
30. Caballero, M. T., M. E. Serra, P. L. Acosta, J. Marzec, L. Gibbons, M. Salim, A. Rodriguez, A. Reynaldi, A. Garcia, D. Bado, et al. 2015. TLR4 genotype and environmental LPS mediate RSV bronchiolitis through Th2 polarization. J. Clin. Invest. 125: 571-582.
31. Kurt-Jones, E. A., L. Popova, L. Kwinn, L. M. Haynes, L. P. Jones, R. A. Tripp, E. E. Walsh, M. W. Freeman, D. T. Golenbock, L. J. Anderson, and R. W. Finberg. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1: 398-401.
32. + dendritic cells are key players in the innate immune control of Cryptosporidium parvum infection in neonatal mice. PLoS Pathog. 9: e1003801.
33. + dendritic cells in cytotoxic T cell immunity. Science 322: 1097-1100.
34. Meunier, S., L. Rapetti, L. Beziaud, C. Pontoux, A. Legrand, and C. Tanchot. 2012. Synergistic CD40 signaling on APCs and CD8 T cells drives efficient CD8 response and memory differentiation. J. Leukoc. Biol. 91: 859-869.
35. + T cell responses to influenza. [Published erratum appears in 2010 Nat. Immunol. 11: 644.] Nat. Immunol. 11: 216-224.
36. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177: 1791-1796.
37. + T cell immunodominance for laboratory strains, smallpox vaccines, and zoonotic isolates of vaccinia virus. J. Immunol. 195: 2263-2272.
38. + T cell expansion. eLife 4: 4.
39. Croft, M. 2003. Costimulation of T cells by OX40, 4-1BB, and CD27. Cytokine Growth Factor Rev. 14: 265-273.
40. West, M. A., R. P. Wallin, S. P. Matthews, H. G. Svensson, R. Zaru, H. G. Ljunggren, A. R. Prescott, and C. Watts. 2004. Enhanced dendritic cell antigen capture via Toll-like receptor-induced actin remodeling. Science 305: 1153-1157.
41. Blander, J. M., and R. Medzhitov. 2004. Regulation of phagosome maturation by signals from Toll-like receptors. Science 304: 1014-1018.
42. Sato, A., and A. Iwasaki. 2004. Induction of antiviral immunity requires Toll-like receptor signaling in both stromal and dendritic cell compartments. Proc. Natl. Acad. Sci. USA 101: 16274-16279.
43. Jakubzick, C., J. Helft, T. J. Kaplan, and G. J. Randolph. 2008. Optimization of methods to study pulmonary dendritic cell migration reveals distinct capacities of DC subsets to acquire soluble versus particulate antigen. J. Immunol. Methods 337: 121-131.
44. Dakic, A., Q. X. Shao, A. D'Amico, M. O'Keeffe, W. F. Chen, K. Shortman, and L. Wu. 2004. Development of the dendritic cell system during mouse ontogeny. J. Immunol. 172: 1018-1027.
45. Upham, J. W., A. Rate, J. Rowe, M. Kusel, P. D. Sly, and P. G. Holt. 2006. Dendritic cell immaturity during infancy restricts the capacity to express vaccine-specific T-cell memory. Infect. Immun. 74: 1106-1112.
46. Kollmann, T. R., J. Crabtree, A. Rein-Weston, D. Blimkie, F. Thommai, X. Y. Wang, P. M. Lavoie, J. Furlong, E. S. Fortuno, III, A. M. Hajjar, et al. 2009. Neonatal innate TLR-mediated responses are distinct from those of adults. J. Immunol. 183: 7150-7160.
47. De Wit, D., S. Tonon, V. Olislagers, S. Goriely, M. Boutriaux, M. Goldman, and F. Willems. 2003. Impaired responses to toll-like receptor 4 and Toll-like receptor 3 ligands in human cord blood. J. Autoimmun. 21: 277-281.
48. Liu, P., M. Jamaluddin, K. Li, R. P. Garofalo, A. Casola, and A. R. Brasier. 2007. Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J. Virol. 81: 1401-1411.
49. Demoor, T., B. C. Petersen, S. Morris, S. Mukherjee, C. Ptaschinski, D. E. De Almeida Nagata, T. Kawai, T. Ito, S. Akira, S. L. Kunkel, et al. 2012. IPS-1 signaling has a nonredundant role in mediating antiviral responses and the clearance of respiratory syncytial virus. J. Immunol. 189: 5942-5953.
50. Lukacs, N. W., J. J. Smit, S. Mukherjee, S. B. Morris, G. Nunez, and D. M. Lindell. 2010. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J. Immunol. 185: 2231-2239.
51. Vissers, M., T. Remijn, M. Oosting, D. J. de Jong, D. A. Diavatopoulos, P. W. Hermans, and G. Ferwerda. 2012. Respiratory syncytial virus infection augments NOD2 signaling in an IFN-β-dependent manner in human primary cells. Eur. J. Immunol. 42: 2727-2735.
52. Marr, N., S. E. Turvey, and N. Grandvaux. 2013. Pathogen recognition receptor crosstalk in respiratory syncytial virus sensing: a host and cell type perspective. Trends Microbiol. 21: 568-574.
53. Levy, O., K. A. Zarember, R. M. Roy, C. Cywes, P. J. Godowski, and M. R. Wessels. 2004. Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J. Immunol. 173: 4627-4634.
54. + B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 22: 467-477.
55. van Haren, S. D., L. Ganapathi, I. Bergelson, D. J. Dowling, M. Banks, R. C. Samuels, S. G. Reed, J. D. Marshall, and O. Levy. 2016. In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant. Cytokine 83: 99-109.
56. + T-cell epitope. PLoS Pathog. 8: e1003042.
57. Dinter, J., E. Duong, N. Y. Lai, M. J. Berberich, G. Kourjian, E. Bracho-Sanchez, D. Chu, H. Su, S. C. Zhang, and S. Le Gall. 2015. Variable processing and cross-presentation of HIV by dendritic cells and macrophages shapes CTL immunodominance and immune escape. PLoS Pathog. 11: e1004725.
58. Eickhoff, S., A. Brewitz, M. Y. Gerner, F. Klauschen, K. Komander, H. Hemmi, N. Garbi, T. Kaisho, R. N. Germain, and W. Kastenmüller. 2015. Robust antiviral immunity requires multiple distinct T cell-dendritic cell interactions. Cell 162: 1322-1337.
59. Murphy, K. M. 2013. Transcriptional control of dendritic cell development. Adv. Immunol. 120: 239-267.
60. Jenkins, M. K., C. A. Chen, G. Jung, D. L. Mueller, and R. H. Schwartz. 1990. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144: 16-22.
61. Suzuki, I., and P. J. Fink. 1998. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med. 187: 123-128.
62. + T-cell responses to influenza virus. J. Virol. 76: 10332-10337.
63. Lin, L. C., I. E. Flesch, and D. C. Tscharke. 2013. Immunodomination during peripheral vaccinia virus infection. PLoS Pathog. 9: e1003329.